Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2019

Open Access 01-12-2019 | Case report

Effective heart-sparing whole lung irradiation using volumetric modulated arc therapy: a case report

Authors: Gen Suzuki, Toshiyuki Ogata, Norihiro Aibe, Hideya Yamazaki, Shigeki Yagyu, Tomoko Iehara, Hajime Hosoi, Kei Yamada

Published in: Journal of Medical Case Reports | Issue 1/2019

Login to get access

Abstract

Background

Late cardiovascular disease-related adverse events are one of the most common causes of premature mortality among long-term survivors of childhood cancer. As it is difficult to reduce the heart dose with traditional anteroposterior–posteroanterior field whole lung irradiation for pulmonary metastasis, improved radiation techniques are highly desirable. We report a case treated with whole lung irradiation using volumetric modulated arc therapy.

Case presentation

A 3-year-old Japanese girl with pulmonary metastases of Wilms’ tumor received 12 Gy in 8 fractions of whole lung irradiation using volumetric modulated arc therapy. The treatment was well tolerated, and the course was completed as planned without any toxicity. We found statistically significant reduced volumetric modulated arc therapy irradiation doses to organs at risk relative to those of the standard anteroposterior–posteroanterior field technique. The mean heart dose was 8.5 Gy for volumetric modulated arc therapy and 12.3 Gy for the anteroposterior–posteroanterior field. The doses to liver and thyroid were also more favorable with volumetric modulated arc therapy than with the anteroposterior–posteroanterior field technique. We confirmed the dosimetric advantages of volumetric modulated arc therapy over anteroposterior–posteroanterior field in whole lung irradiation in terms of superior normal organ protection.

Conclusions

Effective heart sparing is possible for whole lung irradiation using volumetric modulated arc therapy. Large-scale studies using standardized procedures should be conducted to validate our results.
Literature
1.
go back to reference van Dijk IW, Oldenburger F, Cardous-Ubbink MC, Geenen MM, Heinen RC, de Kraker J, et al. Evaluation of late adverse events in long-term Wilms’ tumor survivors. Int J Radiat Oncol Biol Phys. 2010;78:370–8.CrossRef van Dijk IW, Oldenburger F, Cardous-Ubbink MC, Geenen MM, Heinen RC, de Kraker J, et al. Evaluation of late adverse events in long-term Wilms’ tumor survivors. Int J Radiat Oncol Biol Phys. 2010;78:370–8.CrossRef
2.
go back to reference D’Angio GJ, Evans A, Breslow N, Beckwith B, Bishop H, Farewell V, et al. The treatment of Wilms’ Tumor: Results of the second national Wilms’ Tumor study. Cancer. 1981;47:2302–11.CrossRef D’Angio GJ, Evans A, Breslow N, Beckwith B, Bishop H, Farewell V, et al. The treatment of Wilms’ Tumor: Results of the second national Wilms’ Tumor study. Cancer. 1981;47:2302–11.CrossRef
3.
go back to reference Meisel JA, Guthrie KA, Breslow NE, Donaldson SS, Green DM. Significance and management of computed tomography detected pulmonary nodules: A report of the National Wilms Tumor Study Group. Int J Radiat Oncol Biol Phys. 1999;44:579–85.CrossRef Meisel JA, Guthrie KA, Breslow NE, Donaldson SS, Green DM. Significance and management of computed tomography detected pulmonary nodules: A report of the National Wilms Tumor Study Group. Int J Radiat Oncol Biol Phys. 1999;44:579–85.CrossRef
4.
go back to reference Nicolin G, Taylor R, Baughan C, Shannon R, Stevens S, Richardson D, et al. Outcome after pulmonary radiotherapy in Wilms’ tumor patients with pulmonary metastases at diagnosis: A UK Children’s Cancer Study Group, Wilms’ Tumor Working Group Study. Int J Radiat Oncol Biol Phys. 2008;70:175–80.CrossRef Nicolin G, Taylor R, Baughan C, Shannon R, Stevens S, Richardson D, et al. Outcome after pulmonary radiotherapy in Wilms’ tumor patients with pulmonary metastases at diagnosis: A UK Children’s Cancer Study Group, Wilms’ Tumor Working Group Study. Int J Radiat Oncol Biol Phys. 2008;70:175–80.CrossRef
5.
go back to reference Infusino E. Clinical utility of RapidArcTM radiotherapy technology. Cancer Manag Res. 2015;7:345–56.CrossRef Infusino E. Clinical utility of RapidArcTM radiotherapy technology. Cancer Manag Res. 2015;7:345–56.CrossRef
6.
go back to reference Papachristofilou A, Hottinger A-L, Weinhold O, Avcu Y-K, Finazzi T, Diesch T, et al. Heart-sparing volumetric modulated arc therapy for whole lung irradiation. Strahlentherapie und Onkol. 2019;195:77–82.CrossRef Papachristofilou A, Hottinger A-L, Weinhold O, Avcu Y-K, Finazzi T, Diesch T, et al. Heart-sparing volumetric modulated arc therapy for whole lung irradiation. Strahlentherapie und Onkol. 2019;195:77–82.CrossRef
7.
go back to reference Green DM, Cotton CA, Malogolowkin M, Breslow NE, Perlman E, Miser J, et al. Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: a report from the National Wilms Tumor Study Group. Pediatr Blood Cancer. 2007;48:493–9.CrossRef Green DM, Cotton CA, Malogolowkin M, Breslow NE, Perlman E, Miser J, et al. Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: a report from the National Wilms Tumor Study Group. Pediatr Blood Cancer. 2007;48:493–9.CrossRef
8.
go back to reference Kalapurakal JA, Zhang Y, Kepka A, Zawislak B, Sathiaseelan V, Rigsby C, et al. Cardiac-sparing whole lung IMRT in children with lung metastasis. Int J Radiat Oncol Biol Phys. 2013;85:761–7.CrossRef Kalapurakal JA, Zhang Y, Kepka A, Zawislak B, Sathiaseelan V, Rigsby C, et al. Cardiac-sparing whole lung IMRT in children with lung metastasis. Int J Radiat Oncol Biol Phys. 2013;85:761–7.CrossRef
9.
go back to reference Smith MA, Altekruse SF, Adamson PC, Reaman GH, Seibel NL. Declining childhood and adolescent cancer mortality. Cancer. 2014;120:2497–506.CrossRef Smith MA, Altekruse SF, Adamson PC, Reaman GH, Seibel NL. Declining childhood and adolescent cancer mortality. Cancer. 2014;120:2497–506.CrossRef
10.
go back to reference Mertens AC, Liu Q, Neglia JP, Wasilewski K, Leisenring W, Armstrong GT, et al. Cause-specific late mortality among 5-year survivors of childhood cancer: the childhood cancer survivor study. JNCI J Natl Cancer Inst. 2008;100:1368–79.CrossRef Mertens AC, Liu Q, Neglia JP, Wasilewski K, Leisenring W, Armstrong GT, et al. Cause-specific late mortality among 5-year survivors of childhood cancer: the childhood cancer survivor study. JNCI J Natl Cancer Inst. 2008;100:1368–79.CrossRef
11.
go back to reference Reulen RC. Long-term cause-specific mortality among survivors of childhood cancer. JAMA. 2010;304:172–9.CrossRef Reulen RC. Long-term cause-specific mortality among survivors of childhood cancer. JAMA. 2010;304:172–9.CrossRef
12.
go back to reference Tukenova M, Guibout C, Oberlin O, Doyon F, Mousannif A, Haddy N, et al. Role of cancer treatment in long-term overall and cardiovascular mortality after childhood cancer. J Clin Oncol. 2010;28:1308–15.CrossRef Tukenova M, Guibout C, Oberlin O, Doyon F, Mousannif A, Haddy N, et al. Role of cancer treatment in long-term overall and cardiovascular mortality after childhood cancer. J Clin Oncol. 2010;28:1308–15.CrossRef
13.
go back to reference Kero AE, Järvelä LS, Arola M, Malila N, Madanat-Harjuoja LM, Matomäki J, et al. Cardiovascular morbidity in long-term survivors of early-onset cancer: A population-based study. Int J Cancer. 2014;134:664–73.CrossRef Kero AE, Järvelä LS, Arola M, Malila N, Madanat-Harjuoja LM, Matomäki J, et al. Cardiovascular morbidity in long-term survivors of early-onset cancer: A population-based study. Int J Cancer. 2014;134:664–73.CrossRef
14.
go back to reference Lipshultz SE, Adams MJ, Colan SD, Constine LS, Herman EH, Hsu DT, et al. Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: Pathophysiology, course, monitoring, management, prevention, and research directions: A scientific statement from the. Am Heart Assoc Circ. 2013;128:1927–95. Lipshultz SE, Adams MJ, Colan SD, Constine LS, Herman EH, Hsu DT, et al. Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: Pathophysiology, course, monitoring, management, prevention, and research directions: A scientific statement from the. Am Heart Assoc Circ. 2013;128:1927–95.
15.
go back to reference Mulrooney DA, Yeazel MW, Kawashima T, Mertens AC, Mitby P, Stovall M, et al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ. 2009;339:b4606.CrossRef Mulrooney DA, Yeazel MW, Kawashima T, Mertens AC, Mitby P, Stovall M, et al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ. 2009;339:b4606.CrossRef
16.
go back to reference van der Pal HJ, van Dalen EC, van Delden E, van Dijk IW, Kok WE, Geskus RB, et al. High risk of symptomatic cardiac events in childhood cancer survivors. J Clin Oncol. 2012;30:1429–37.CrossRef van der Pal HJ, van Dalen EC, van Delden E, van Dijk IW, Kok WE, Geskus RB, et al. High risk of symptomatic cardiac events in childhood cancer survivors. J Clin Oncol. 2012;30:1429–37.CrossRef
17.
go back to reference Haddy N, Diallo S, El-Fayech C, Schwartz B, Pein F, Hawkins M, et al. Cardiac diseases following childhood cancer treatment: Cohort study. Circulation. 2016;133:31–8.CrossRef Haddy N, Diallo S, El-Fayech C, Schwartz B, Pein F, Hawkins M, et al. Cardiac diseases following childhood cancer treatment: Cohort study. Circulation. 2016;133:31–8.CrossRef
18.
go back to reference Schellong G, Riepenhausen M, Bruch C, Kotthoff S, Vogt J, Bölling T, et al. Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for Hodgkin disease in children and adolescents: Report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD studies. Pediatr Blood Cancer. 2010;55:1145–52.CrossRef Schellong G, Riepenhausen M, Bruch C, Kotthoff S, Vogt J, Bölling T, et al. Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for Hodgkin disease in children and adolescents: Report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD studies. Pediatr Blood Cancer. 2010;55:1145–52.CrossRef
19.
go back to reference Galper SL, Yu JB, Mauch PM, Strasser JF, Silver B, LaCasce A, et al. Clinically significant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation. Blood. 2011;117:412–8.CrossRef Galper SL, Yu JB, Mauch PM, Strasser JF, Silver B, LaCasce A, et al. Clinically significant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation. Blood. 2011;117:412–8.CrossRef
20.
go back to reference Mulrooney DA, Nunnery SE, Armstrong GT, Ness KK, Srivastava D, Donovan FD, et al. Coronary artery disease detected by coronary computed tomography angiography in adult survivors of childhood Hodgkin lymphoma. Cancer. 2014;120:3536–44.CrossRef Mulrooney DA, Nunnery SE, Armstrong GT, Ness KK, Srivastava D, Donovan FD, et al. Coronary artery disease detected by coronary computed tomography angiography in adult survivors of childhood Hodgkin lymphoma. Cancer. 2014;120:3536–44.CrossRef
21.
go back to reference Pein F, Sakiroglu O, Dahan M, Lebidois J, Merlet P, Shamsaldin A, et al. Cardiac abnormalities 15 years and more after adriamycin therapy in 229 childhood survivors of a solid tumour at the Institut Gustave Roussy. Br J Cancer. 2004;91:37–44.CrossRef Pein F, Sakiroglu O, Dahan M, Lebidois J, Merlet P, Shamsaldin A, et al. Cardiac abnormalities 15 years and more after adriamycin therapy in 229 childhood survivors of a solid tumour at the Institut Gustave Roussy. Br J Cancer. 2004;91:37–44.CrossRef
22.
go back to reference Green DM, Grigoriev YA, Nan B, Takashima JR, Norkool PA, D'Angio GJ, et al. Congestive heart failure after treatment for Wilms’ tumor: a report from the National Wilms’ Tumor Study Group. J Clin Oncol. 2001;19:1926–34.CrossRef Green DM, Grigoriev YA, Nan B, Takashima JR, Norkool PA, D'Angio GJ, et al. Congestive heart failure after treatment for Wilms’ tumor: a report from the National Wilms’ Tumor Study Group. J Clin Oncol. 2001;19:1926–34.CrossRef
23.
go back to reference Warwick AB, Kalapurakal JA, Ou S-S, Green DM, Norkool PA, Peterson SM, et al. Portal hypertension in children with Wilms’ tumor: a report from the National Wilms’ Tumor Study Group. Int J Radiat Oncol. 2010;77:210–6.CrossRef Warwick AB, Kalapurakal JA, Ou S-S, Green DM, Norkool PA, Peterson SM, et al. Portal hypertension in children with Wilms’ tumor: a report from the National Wilms’ Tumor Study Group. Int J Radiat Oncol. 2010;77:210–6.CrossRef
24.
go back to reference Kalapurakal JA, Gopalakrishnan M, Walterhouse DO, Rigsby CK, Rademaker A, Helenowski I, et al. Cardiac-sparing whole lung IMRT in patients with pediatric tumors and lung metastasis: final report of a prospective multicenter clinical trial. Int J Radiat Oncol Biol Phys. 2019;103:28–37.CrossRef Kalapurakal JA, Gopalakrishnan M, Walterhouse DO, Rigsby CK, Rademaker A, Helenowski I, et al. Cardiac-sparing whole lung IMRT in patients with pediatric tumors and lung metastasis: final report of a prospective multicenter clinical trial. Int J Radiat Oncol Biol Phys. 2019;103:28–37.CrossRef
25.
go back to reference Palma D, Vollans E, James K, Nakano S, Moiseenko V, Shaffer R, et al. Volumetric modulated arc therapy for delivery of prostate radiotherapy: comparison with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy. Int J Radiat Oncol. 2008;72:996–1001.CrossRef Palma D, Vollans E, James K, Nakano S, Moiseenko V, Shaffer R, et al. Volumetric modulated arc therapy for delivery of prostate radiotherapy: comparison with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy. Int J Radiat Oncol. 2008;72:996–1001.CrossRef
26.
go back to reference Clivio A, Fogliata A, Franzetti-Pellanda A, Nicolini G, Vanetti E, Wyttenbach R, et al. Volumetric-modulated arc radiotherapy for carcinomas of the anal canal: A treatment planning comparison with fixed field IMRT. Radiother Oncol. 2009;92:118–24.CrossRef Clivio A, Fogliata A, Franzetti-Pellanda A, Nicolini G, Vanetti E, Wyttenbach R, et al. Volumetric-modulated arc radiotherapy for carcinomas of the anal canal: A treatment planning comparison with fixed field IMRT. Radiother Oncol. 2009;92:118–24.CrossRef
27.
go back to reference Cozzi L, Dinshaw KA, Shrivastava SK, Mahantshetty U, Engineer R, Deshpande DD, et al. A treatment planning study comparing volumetric arc modulation with RapidArc and fixed field IMRT for cervix uteri radiotherapy. Radiother Oncol. 2008;89:180–91.CrossRef Cozzi L, Dinshaw KA, Shrivastava SK, Mahantshetty U, Engineer R, Deshpande DD, et al. A treatment planning study comparing volumetric arc modulation with RapidArc and fixed field IMRT for cervix uteri radiotherapy. Radiother Oncol. 2008;89:180–91.CrossRef
28.
go back to reference Shaffer R, Nichol AM, Vollans E, Fong M, Nakano S, Moiseenko V, et al. A comparison of volumetric modulated arc therapy and conventional intensity-modulated radiotherapy for frontal and temporal high-grade gliomas. Int J Radiat Oncol. 2010;76:1177–84.CrossRef Shaffer R, Nichol AM, Vollans E, Fong M, Nakano S, Moiseenko V, et al. A comparison of volumetric modulated arc therapy and conventional intensity-modulated radiotherapy for frontal and temporal high-grade gliomas. Int J Radiat Oncol. 2010;76:1177–84.CrossRef
29.
go back to reference Verbakel WFAR, Cuijpers JP, Hoffmans D, Bieker M, Slotman BJ, Senan S. Volumetric intensity-modulated arc therapy vs. conventional IMRT in head-and-neck cancer: a comparative planning and Dosimetric Study. Int J Radiat Oncol. 2009;74:252–9.CrossRef Verbakel WFAR, Cuijpers JP, Hoffmans D, Bieker M, Slotman BJ, Senan S. Volumetric intensity-modulated arc therapy vs. conventional IMRT in head-and-neck cancer: a comparative planning and Dosimetric Study. Int J Radiat Oncol. 2009;74:252–9.CrossRef
Metadata
Title
Effective heart-sparing whole lung irradiation using volumetric modulated arc therapy: a case report
Authors
Gen Suzuki
Toshiyuki Ogata
Norihiro Aibe
Hideya Yamazaki
Shigeki Yagyu
Tomoko Iehara
Hajime Hosoi
Kei Yamada
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2019
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-019-2209-2

Other articles of this Issue 1/2019

Journal of Medical Case Reports 1/2019 Go to the issue